Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen (Q61268441)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593334%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593334%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593334%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Paul Zajac

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593334%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Schütz A

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593334%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Oertli D

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593334%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Marti WR

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593334%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Noppen C

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593334%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Spagnoli GC

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593334%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Heberer M

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593334%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593334%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593334%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593334%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593334%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

655-661

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593334%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700351

12 November 2019

exact match

0 references

cites work

Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700351

7 January 2021

Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700351

7 January 2021

Processing and delivery of peptides presented by MHC class I molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700351

7 January 2021

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700351

7 January 2021

Design and evaluation of antigen-specific vaccination strategies against cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700351

7 January 2021

Therapeutic vaccination for cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700351

7 January 2021

Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700351

7 January 2021

Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700351

7 January 2021

Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700351

7 January 2021

Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700351

7 January 2021

Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700351

7 January 2021

Generating MHC class I ligands from viral gene products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700351

7 January 2021

Generation of tumoricidal cytotoxic T lymphocytes from healthy donors after in vitro stimulation with a replication-incompetent vaccinia virus encoding MART-1/Melan-A 27-35 epitope

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700351

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700351

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593334%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference